Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Hydrocortisone

Hepatitis B virus reactivation and off label use: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Borges MASB, et al. HEPATITIS B AND ITS CHALLENGES: REACTIVATION AFTER COVID-19 AND CORTICOSTEROID USE IN DIALYTIC PATIENT Brazilian Journal of Infectious Diseases 26 (Suppl. 1): 58, Jan 2022. Available from: URL: http://doi.org/10.1016/j.bjid.2021.102102 [Portuguese abstract; summarised from a translation] Borges MASB, et al. HEPATITIS B AND ITS CHALLENGES: REACTIVATION AFTER COVID-19 AND CORTICOSTEROID USE IN DIALYTIC PATIENT Brazilian Journal of Infectious Diseases 26 (Suppl. 1): 58, Jan 2022. Available from: URL: http://​doi.​org/​10.​1016/​j.​bjid.​2021.​102102 [Portuguese abstract; summarised from a translation]
Metadaten
Titel
Hydrocortisone
Hepatitis B virus reactivation and off label use: case report
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-30824-8

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Plasma

Case report

Multiple drugs